Yondelis CHINA . Xian Janssen Actualiza el Ensayo de Fase III que esta Llevando a cabo in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma .

A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma .

ClinicalTrials Identifier: NCT01692678
Updated: 2017_01_30 .

This study is ongoing, but not recruiting participants.

Sponsor:

Xian-Janssen Pharmaceutical Ltd.

Information provided by (Responsible Party):

Xian-Janssen Pharmaceutical Ltd.

ClinicalTrials.gov Identifier:

NCT01692678

First received: August 6, 2012

Last updated: January 30, 2017

Last verified: January 2017

Estimated Primary Completion Date:March 2018 (Final data collection date for primary outcome measure) .

Locations

China:
Beijing, China
Guangzhou, China
Nanjing, China
Shanghai, China
Tianjin, China

Sponsors and Collaborators :

Xian-Janssen Pharmaceutical Ltd.

...